Panacea Life Sciences Holdings, Inc. (PLSH)

PLSH Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	2.38	1.63	2.06	9.02	0.35
Revenue Growth (YoY)	46.59%	-21.01%	-77.16%	2508.69%	-
Cost of Revenue	2.12	1.23	1.52	7.02	2.05
Gross Profit	0.27	0.4	0.54	2	-1.7
Selling, General & Admin	5.81	1.09	1.52	2.81	8.95
Research & Development	0	0	0	0	0.02
Other Operating Expenses	0	4.7	4.56	4.45	4.12
Operating Expenses	5.81	5.79	6.08	7.26	8.97
Operating Income	-5.55	-5.4	-5.54	-5.26	-10.67
Interest Expense	0.68	2.05	1.11	1.51	0.48
Other Expense / Income	1.79	1.7	-1.86	-1.54	-1.13
Pretax Income	-8.02	-9.14	-4.78	-5.23	-10.02
Income Tax	0	1.96	1.34	1.76	-0.54
Net Income	-8.02	-11.1	-6.12	-6.99	-9.48
Shares Outstanding (Basic)	17	15	18	17	1
Shares Outstanding (Diluted)	17	15	18	17	1
Shares Change	11.88%	-16.60%	5.35%	1297.20%	-74.59%
EPS (Basic)	-0.48	-0.75	-0.34	-0.41	-7.83
EPS (Diluted)	-0.48	-0.75	-0.34	-0.41	-7.83
Free Cash Flow	-1.59	-2.64	-4.09	-10.85	-6.29
Free Cash Flow Per Share	-0.10	-0.18	-0.23	-0.64	-5.19
Gross Margin	11.13%	24.37%	26.25%	22.15%	-491.92%
Operating Margin	-232.55%	-331.81%	-269.00%	-58.31%	-3087.46%
Profit Margin	-336.08%	-682.14%	-297.35%	-77.57%	-2742.81%
Free Cash Flow Margin	-66.66%	-162.47%	-198.34%	-120.28%	-1818.88%
EBITDA	-3.83	-3.41	-4.34	-4.66	-9.78
EBITDA Margin	-160.72%	-209.44%	-210.66%	-51.69%	-2829.33%
Depreciation & Amortization	1.71	1.73	0.97	0.34	0.89
EBIT	-5.55	-5.14	-5.3	-5.01	-10.67
EBIT Margin	-232.55%	-315.84%	-257.52%	-55.52%	-3087.46%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.